Profund Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.09M | Buy |
31,013
+1,881
| +6% | +$125K | 0.06% | 190 |
|
|
2026
Q1 | $1.83M | Sell |
29,132
-8,157
| -22% | -$568K | 0.07% | 227 |
|
|
2025
Q4 | $2.47M | Buy |
37,289
+3,697
| +11% | +$239K | 0.08% | 169 |
|
|
2025
Q3 | $2.26M | Sell |
33,592
-1,063
| -3% | -$84.1K | 0.07% | 170 |
|
|
2025
Q2 | $3.03M | Buy |
34,655
+3,829
| +12% | +$300K | 0.11% | 128 |
|
|
2025
Q1 | $2.11M | Sell |
30,826
-4,215
| -12% | -$344K | 0.09% | 167 |
|
|
2024
Q4 | $2.73M | Buy |
35,041
+1,922
| +6% | +$142K | 0.1% | 140 |
|
|
2024
Q3 | $2.22M | Sell |
33,119
-1,853
| -5% | -$152K | 0.08% | 170 |
|
|
2024
Q2 | $3.97M | Buy |
34,972
+656
| +2% | +$82.9K | 0.15% | 102 |
|
|
2024
Q1 | $4.76M | Sell |
34,316
-1,751
| -5% | -$220K | 0.19% | 86 |
|
|
2023
Q4 | $4.48M | Buy |
36,067
+5,523
| +18% | +$564K | 0.19% | 92 |
|
|
2023
Q3 | $2.85M | Buy |
30,544
+7,185
| +31% | +$810K | 0.16% | 112 |
|
|
2023
Q2 | $3M | Buy |
23,359
+1,317
| +6% | +$159K | 0.16% | 97 |
|
|
2023
Q1 | $2.56M | Sell |
22,042
-841
| -4% | -$94.1K | 0.16% | 112 |
|
|
2022
Q4 | $2.59M | Sell |
22,883
-1,476
| -6% | -$162K | 0.17% | 112 |
|
|
2022
Q3 | $1.96M | Sell |
24,359
-1,624
| -6% | -$138K | 0.14% | 134 |
|
|
2022
Q2 | $1.94M | Sell |
25,983
-4,929
| -16% | -$450K | 0.12% | 151 |
|
|
2022
Q1 | $3.95M | Sell |
30,912
-10,824
| -26% | -$1.18M | 0.17% | 102 |
|
|
2021
Q4 | $5.6M | Sell |
41,736
-804
| -2% | -$116K | 0.18% | 92 |
|
|
2021
Q3 | $5.82M | Buy |
42,540
+3,260
| +8% | +$411K | 0.2% | 87 |
|
|
2021
Q2 | $4.19M | Sell |
39,280
-632
| -2% | -$60.7K | 0.14% | 118 |
|
|
2021
Q1 | $3.59M | Buy |
39,912
+7,492
| +23% | +$703K | 0.14% | 127 |
|
|
2020
Q4 | $3M | Buy |
32,420
+1,144
| +4% | +$102K | 0.13% | 142 |
|
|
2020
Q3 | $3.22M | Sell |
31,276
-100
| -0.3% | -$10.4K | 0.17% | 108 |
|
|
2020
Q2 | $3.18M | Buy |
31,376
+26,844
| +592% | +$2.4M | 0.18% | 105 |
|
|
2020
Q1 | $305K | Sell |
4,532
-1,260
| -22% | -$78.4K | 0.02% | 491 |
|
|
2019
Q4 | $317K | Buy |
+5,792
| New | +$275K | 0.01% | 889 |
|
|
2019
Q3 | – | Sell |
-5,932
| Closed | -$222K | – | 1295 |
|
|
2019
Q2 | $222K | Sell |
5,932
-3,180
| -35% | -$100K | 0.01% | 1083 |
|
|
2019
Q1 | $271K | Buy |
9,112
+676
| +8% | +$23.8K | 0.01% | 975 |
|
|
2018
Q4 | $253K | Sell |
8,436
-1,072
| -11% | -$34K | 0.02% | 882 |
|
|
2018
Q3 | $340K | Buy |
+9,508
| New | +$295K | 0.01% | 1094 |
|
|
2016
Q4 | – | Sell |
-9,376
| Closed | -$205K | – | 1561 |
|
|
2016
Q3 | $205K | Buy |
+9,376
| New | +$209K | 0.01% | 1317 |
|
|
2016
Q1 | – | Sell |
-13,072
| Closed | -$268K | – | 1459 |
|
|
2015
Q4 | $268K | Sell |
13,072
-3,048
| -19% | -$63.4K | 0.01% | 1016 |
|
|
2015
Q3 | $346K | Sell |
16,120
-3,732
| -19% | -$83.3K | 0.02% | 741 |
|
|
2015
Q2 | $397K | Sell |
19,852
-8,820
| -31% | -$155K | 0.02% | 923 |
|
|
2015
Q1 | $447K | Buy |
28,672
+4,216
| +17% | +$63.7K | 0.02% | 969 |
|
|
2014
Q4 | $337K | Buy |
24,456
+2,152
| +10% | +$26.3K | 0.01% | 1058 |
|
|
2014
Q3 | $223K | Buy |
22,304
+104
| +0.5% | +$1.06K | 0.01% | 1170 |
|
|
2014
Q2 | $220K | Sell |
22,200
-1,800
| -8% | -$15.9K | 0.01% | 1387 |
|
|
2014
Q1 | $248K | Buy |
+24,000
| New | +$248K | 0.01% | 1326 |
|
Other funds holding DXCM
Profund Advisors's DXCM Position: Q2 2026 in Review
Profund Advisors increased its DexCom (DXCM) stake by 6.5% in Q2 2026, buying an estimated $125K and bringing the position to 31,013 shares worth $2.09M. The position accounts for 0.06% of the portfolio, ranked #190.
Profund Advisors first reported a position in DXCM in Q1 2014 and has held it in 40 quarters since. The position peaked at $5.82M in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Profund Advisors held 31,013 shares of DexCom worth $2.09M as of Q2 2026.
- Profund Advisors bought 1,881 DexCom shares in Q2 2026, an estimated $125K.
- DexCom made up 0.06% of Profund Advisors's portfolio in Q2 2026, its #190 holding.
- Profund Advisors first reported a position in DexCom in Q1 2014 and has held it in 40 quarters since.
- Profund Advisors's DexCom position peaked at $5.82M in Q3 2021.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.